Transgenic avian-derived recombinant human interferon-a2b (AVI-005) in healthy subjects: an open-label, single-dose, controlled study

Tarun B. Patel, E Péquignot, Steven Parker, Mark C. Leavitt, Howard Greenberg, Walter K. Kraft

International Journal of Clinical Pharmacology and Therapeutics · 2007 · 10 citations · 9 references

Abstract

AVI-005 demonstrates biological activity and pharmaco-kinetic properties in humans that support further development.

References

9